DCC-2036: A novel switch pocket inhibitor of ABL tyrosine kinase with therapeutic efficacy against BCR-ABL T315I in vitro and in a CML mouse model - Van Etten, R A; Chan, W W; Zaleskas, V M; Evangelista, P; Lazarides, K; Peng, C; Li, S; Wise, S C; Petillo, P; Flynn, D L (Blood, 2007)